A5085995049- HIV Research and Treatment
- HIV/AIDS Research and Interventions
- HIV/AIDS drug development and treatment
- HIV-related health complications and treatments
- Hepatitis C virus research
- Pneumocystis jirovecii pneumonia detection and treatment
- HIV, Drug Use, Sexual Risk
- Cytomegalovirus and herpesvirus research
- Hepatitis B Virus Studies
- Liver Disease Diagnosis and Treatment
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Telomeres, Telomerase, and Senescence
- HIV/AIDS oral health manifestations
- Full-Duplex Wireless Communications
- Polyomavirus and related diseases
- Tuberculosis Research and Epidemiology
- Helicobacter pylori-related gastroenterology studies
- Microscopic Colitis
- Herpesvirus Infections and Treatments
- Immunodeficiency and Autoimmune Disorders
- Diagnosis and treatment of tuberculosis
- Gastrointestinal disorders and treatments
- Lipoproteins and Cardiovascular Health
- Syphilis Diagnosis and Treatment
- Eosinophilic Esophagitis
University of Belgrade
2014-2023
University Children's Hospital, Belgrade
2020
Hospital for Tropical Diseases
1996-2014
Univerzitetski Klinički Centar Srbije
2007-2014
Institut za kardiovaskularne bolesti Dedinje
2011-2012
Czech Academy of Sciences, Institute of Microbiology
2012
Infectious Diseases Institute
2012
Institute for Medical Research
1997
European Society of Clinical Microbiology and Infectious Diseases
1997
To describe changes in the prevalence of comorbidities and risk factors among HIV-positive individuals EuroSIDA study. Comparison two cross-sectional cohorts adults under active follow-up 2006 2014. Baseline demographics were described. Factors associated with chronic kidney disease (CKD) cardiovascular (CVD) assessed by logistic regression modelling using generalized estimating equations. Nine thousand, seven hundred ninety-eight during 12 882 Compared study participants 2006, those 2014...
IntroductionThe SARS-CoV-2 pandemic has hit the European region disproportionately. Many HIV clinics share staff and logistics with infectious disease facilities, which are now on frontline in tackling COVID-19. Therefore, this study investigated impact of current situation care continuity antiretroviral treatment (ART) supplies CEE countries.MethodsThe Euroguidelines Central Eastern Europe (ECEE) Network Group was established February 2016 to review standards for region. The group consists...
Background It is becoming increasingly clear that, during successful highly active antiretroviral therapy (HAART), a proportion of treated patients develop opportunistic infections (OIs), referred to in this setting as immune restoration disease (IRD). We examined the risk developing IRD HAART‐treated HIV‐infected patients. Methods A retrospective study cohort including all 389 with HAART between 1 January 1998 and 31 May 2004 our HIV unit was performed evaluate occurrence factors for HAART....
Binary file ES_Abstracts_Final_ECDC.txt matches
Objectives All HIV /hepatitis C virus ( HCV )‐coinfected patients with chronic infection and ≥ F 2 fibrosis should be considered for therapy. This study aimed to determine the rate of treatment uptake among coinfected in Europe. Methods EuroSIDA viraemic were included study. Poisson regression was used identify temporal changes regional differences uptake. Results A total 1984 study, a median follow‐up time 168 months [interquartile range IQR ) 121–204 months]. To date, 501 (25.3%) /...
The impact of immunosuppression despite virological suppression (immuno-virological discordance, ID) on the risk developing fatal and non-fatal AIDS/non-AIDS events is unclear remains to be elucidated.Patients in EuroSIDA starting at least 1 new antiretroviral drug with CD4<350 cells/µl viral load (VL)>500 copies/mL were followed-up from first day VL< = 50 copies/ml until a fatal/non-fatal non-AIDS/AIDS event. Considered non-AIDS included malignancies, pancreatitis, severe liver disease...
Mucocutaneous manifestations such as oral candidiasis (OC) and seborrheic dermatitis (SD) are very common HIV-related opportunistic events usually initial markers of immunodeficiency.The purpose this study was to evaluate the efficacy highly active antiretroviral therapy (HAART) in regression HIV-associated OC SD.In a prospective study, 120 HIV-infected patients with SD were divided into two groups: HAART-treated (group 1, n=76) non-HAART-treated 2, n=44). Non-HAART-treated given...
Background/objectives: Inadequate HIV care for hard-to-reach populations may result in failing the UNAIDS 90–90–90 goal. Therefore, we aimed to review continuum of and each step Central, Eastern South Europe.Methods: Euro-guidelines Central Europe (ECEE) Network Group were created February 2016. The aim network was standards countries region. Information about stage collected through on-line surveys. Respondents ECEE members chosen based on their expertise involvement national care. Data...
AimTo compare four cardiovascular disease (CVD) risk models and to assess the prevalence of eligibility for lipid lowering therapy according 2013 American College Cardiology/American Heart Association (ACC/AHA) guidelines, European AIDS Clinical Society Guidelines (EACS), Cardiology Atherosclerosis (ESC/EAS) guidelines CVD prevention in HIV infected patients on antiretroviral therapy.MethodsWe performed a cross-sectional analysis 254 consecutive aged 40 79 years who received at least 12...
Peripheral neuropathy (PN) is a well-known adverse effect of treatment with nucleoside reverse transcriptase inhibitors (NRTIs). We performed prospective follow-up study in HIV-infected patients on antiretroviral therapy containing NRTIs. The objective this was to examine the incidence PN among using NRTI drugs. Data were obtained medical records continuously monitored for efficacy and toxicity therapy. incident cases examined. Incidence rates calculated each regimen that included...
A prospective study to evaluate the incidence of herpes zoster (HZ) as an immune restoration disease in patients with AIDS during highly active antiretroviral therapy (HAART) was conducted a series 115 diagnosed initiated on HAART between 1 January 2000 and 31 July 2001. Of these, single dermatomal HZ episode occurred 14 (12%) within one 15 months (median eight months). The were similar non-HZ age, sex, HIV transmission risk factor, but had more advanced disease. Compared baseline values,...
Clostridium difficile is the leading cause of hospital-acquired diarrhoea. There no defined protocol for treating severe infection (CDI) refractory to vancomycin or and metronidazole combination therapy. The aim this study was evaluate rate clinical cure, time resolution diarrhoea recurrence in patients with CDI treated oral teicoplanin.A one-year prospective carried out Clinic Infectious Tropical Diseases, Clinical Center Serbia. Patients complicated who failed respond intravenous therapy...
Acute pancreatitis (AP) is a well-known adverse effect of nucleoside reverse transcriptase inhibitors (NRTIs). Therefore, we performed prospective, cohort study to examine the incidence rates (IRs) and rate ratios (RRs) AP for each NRTI. A total 116 HIV patients were included in final analysis comprising 445.6 person-years follow-up. Twelve cases recorded. The lowest IR was didanosine (ddI) (IR=0.03 per 100 person-years, 95% confidence interval [CI] = 0.01-0.05), highest ddI + stavudine...
Background: Granulocytic sarcoma (chloroma) occurs primarily in patients with acute myelogenous leukemia although it can also appear connection other myeloproliferative disorders. Case Report: We present the case of a 52-year-old human immunodeficiency virus (HIV)-positive female patient CD4+ count 321 cells/ml, who developed an alveolar granulocytic mandible. Pathological analysis tumor mass showed infiltrate immature cells which were positive for CD13, CD33, CD15, CD11b, and CD64, negative...
In Serbia, the first cases of HIV infection were reported in 1985, whereas antiretroviral (ARV) therapy has been use since 1987. With this study we aimed to assess occurrence and pattern resistance mutations among newly diagnosed patients period 2002-2011. The prospectively included 181 adult patients. Genotypic HIV-1 drug testing was performed scored according 2009 WHO list for surveillance (SDRMs). A bioinformatic approach used estimate duration by calculating percentage ambiguous...